Acarbose是α-葡糖苷酶抑制剂,有抗2型糖尿病功效。
MoreAvitinib (AC0010) a novel mutant-selective third-generation irreversible EGFR inhibitor is currently in phase I clinical trial.
MoreAcarbose是α-葡糖苷酶抑制剂,有抗2型糖尿病功效。
MoreAvitinib (AC0010) a novel mutant-selective third-generation irreversible EGFR inhibitor is currently in phase I clinical trial.
More